We are live on ! Find out more
Mackenzie Financial

Mackenzie Financial Portfolio holdings

AUM $100B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+8.32%
1 Year Est. Return
+36.93%
3 Year Est. Return
+93.95%
5 Year Est. Return
+113.13%
10 Year Est. Return
+336.84%
AUM
$71.9B
AUM Growth
+$6.29B
Cap. Flow
+$1.27B
Cap. Flow %
1.76%
Top 10 Hldgs %
21.92%
Holding
1,308
New
190
Increased
633
Reduced
385
Closed
76

Sector Composition

Rank Sector Weight
1 Financials 25.75%
2 Technology 17.32%
3 Industrials 11.57%
4 Healthcare 9.15%
5 Consumer Discretionary 7.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NBIS
1126
Nebius Group N.V.
NBIS
$57.7B
$235K ﹤0.01%
3,319
+76
+2% +$4.99K
BCC icon
1127
Boise Cascade
BCC
$2.63B
$233K ﹤0.01%
+3,994
New +$259K
NPO icon
1128
Enpro
NPO
$6.01B
$233K ﹤0.01%
+2,402
New +$219K
PACB icon
1129
Pacific Biosciences
PACB
$420M
$233K ﹤0.01%
+6,675
New +$194K
PMT
1130
PennyMac Mortgage Investment
PMT
$789M
$233K ﹤0.01%
+11,058
New +$221K
SEEL
1131
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$231K ﹤0.01%
+23
New +$378K
CHRD icon
1132
Chord Energy
CHRD
$8.27B
$230K ﹤0.01%
+2,285
New +$188K
EPRT icon
1133
Essential Properties Realty Trust
EPRT
$6.22B
$230K ﹤0.01%
+8,520
New +$221K
IQ icon
1134
iQIYI
IQ
$960M
$229K ﹤0.01%
+14,707
New +$219K
RDFN
1135
DELISTED
Redfin
RDFN
$229K ﹤0.01%
+3,606
New +$220K
SVM
1136
Silvercorp Metals
SVM
$2.53B
$229K ﹤0.01%
41,816
-34,894
-45% -$203K
EBS icon
1137
Emergent Biosolutions
EBS
$327M
$228K ﹤0.01%
+3,617
New +$232K
EHC icon
1138
PUT
Encompass Health
EHC
$12.1B
$228K ﹤0.01%
+3,673
New +$245K
FOX icon
1139
Fox Class B
FOX
$25.7B
$227K ﹤0.01%
6,442
-3,716
-37% -$134K
SIGA icon
1140
SIGA Technologies
SIGA
$226M
$227K ﹤0.01%
+36,090
New +$248K
TTEK icon
1141
Tetra Tech
TTEK
$9.4B
$227K ﹤0.01%
+9,310
New +$234K
SCHL icon
1142
Scholastic
SCHL
$666M
$225K ﹤0.01%
+5,932
New +$200K
FOXF icon
1143
Fox Factory Holding Corp
FOXF
$823M
$224K ﹤0.01%
+1,441
New +$214K
UPWK icon
1144
Upwork
UPWK
$1.09B
$224K ﹤0.01%
+3,848
New +$181K
BBIO icon
1145
BridgeBio Pharma
BBIO
$14.1B
$223K ﹤0.01%
+3,652
New +$209K
UFPI icon
1146
UFP Industries
UFPI
$4.47B
$222K ﹤0.01%
+2,991
New +$236K
VCYT icon
1147
Veracyte
VCYT
$3.31B
$219K ﹤0.01%
+5,490
New +$235K
FFIN icon
1148
First Financial Bankshares
FFIN
$4.77B
$218K ﹤0.01%
+4,445
New +$218K
IVZ icon
1149
Invesco
IVZ
$13.9B
$218K ﹤0.01%
+8,137
New +$222K
NWL icon
1150
Newell Brands
NWL
$2.46B
$218K ﹤0.01%
+7,930
New +$219K

Similar funds

Mackenzie Financial's Q2 2021 Portfolio in Review

As of Q2 2021, Mackenzie Financial held 1,308 positions worth $71.9B, up 9.6% from $65.6B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Mackenzie Financial's Q2 2021 filing shows 190 new, 633 increased, 385 reduced and 76 closed positions. Its largest new stake was TELUS International: 8,514,898 shares worth $264M. The largest sale was Shaw Communications Inc., an estimated $205M.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 26% a quarter earlier, followed by Technology and Industrials.

  • Mackenzie Financial's largest Q2 2021 buy was TELUS International: 8,514,898 shares worth $264M.
  • Mackenzie Financial added most to Moody's in Q2 2021, an estimated $209M increase.
  • Mackenzie Financial's biggest Q2 2021 reduction was Shaw Communications Inc., cutting an estimated $205M.
  • Mackenzie Financial fully exited iShare MSCI Eurozone ETF in Q2 2021, selling an estimated $49.5M.
  • Mackenzie Financial's ten largest holdings make up 22% of its $71.9B portfolio in Q2 2021.
  • Mackenzie Financial opened 190 new positions and closed 76 in Q2 2021.
  • Mackenzie Financial's portfolio value rose 9.6% quarter-over-quarter to $71.9B.

Based on Mackenzie Financial's 13F filing for Q2 2021, filed 11 Aug 2021.